The stock market is ending the year on a down note. The Dow Jones Industrial Average is lower today. Investors are reacting to some big news from the FDA. This news has caused biotech stocks to drop. It's a reminder that the market can be unpredictable. The FDA's announcement has sent shockwaves th
BridgeBio Pharma, a biotech company focused on genetic diseases, has seen a remarkable surge in its stock price, reaching an all-time high of $75. 10. Over the past year, the stock has soared by 145%, catching the attention of both Wall Street and individual investors. The company's market value sta
Biotech stocks have had a rough time since their peak in early 2021. They didn't join the market's rebound in 2022, but this summer brought a change. These stocks are tricky because most of them are in the early stages of development. They often don't have earnings or steady revenue, relying instead
